Global Amniocentesis Needle Market Size study & Forecast, by Type (100 to 150 mm, Smaller Than 100 mm, Larger Than 150 mm) by Procedure (Amniocentesis Procedures, Amnioreduction Procedures, Fetal Blood Transfusion, Amnioinfusion Procedure, Cordocentesis P

Global Amniocentesis Needle Market Size study & Forecast, by Type (100 to 150 mm, Smaller Than 100 mm, Larger Than 150 mm) by Procedure (Amniocentesis Procedures, Amnioreduction Procedures, Fetal Blood Transfusion, Amnioinfusion Procedure, Cordocentesis Procedure), by End-Use (Hospitals, Diagnostics centers, Clinics, Others) and Regional Analysis, 2023-2030

Global Amniocentesis Needle Market is valued approximately at USD 175.91 Million in 2022 and is anticipated to grow with a healthy growth rate of more than 6.85% over the forecast period 2023-2030. An amniocentesis needle is a specialized medical instrument used in a diagnostic procedure called amniocentesis. Amniocentesis is a medical procedure often conducted during pregnancy for diagnostic purposes and the amniocentesis needle plays a crucial role in this process. Amniocentesis, also referred to as the amniotic fluid test, is a prenatal diagnostic procedure utilized to identify chromosomal abnormalities, infections, and even determine the sex of the fetus. During this test, approximately 30 cubic centimeters of amniotic fluid is carefully collected from the womb, providing valuable insights into potential genetic disorders in the developing baby. The amniocentesis needles are designed with an end featuring a spiral structure, enhancing visibility in ultrasound examinations for precise and transparent procedures. The Amniocentesis Needle market is expanding because of factors such as the rising prevalence of chronic diseases among expectant mothers, the rising incidence of genetic disorders, and increasing maternal age.

The surge in genetic disorders among newborns, coupled with growing awareness of prenatal testing, has fueled an escalating demand for amniocentesis procedures. For instance, a 2022 report by MJH Life Sciences highlighted a global rise in the prevalence of genetic diseases, revealing that globally approximately 300,000 infants are born with sickle cell disease annually. This condition affects nearly 5% of the global population and stands as the most common genetic disorder in the U.S. Such concerning statistics underscore the paramount importance of early detection and diagnosis of genetic abnormalities in fetuses. Consequently, the market for amniocentesis needles is witnessing expansion, given its pivotal role in prenatal care, facilitating the detection of chromosomal and genetic disorders. In addition, Government initiatives promoting prenatal care and genetic screening programs and advancements in Needle Design and Materials, rising healthcare spending globally is creating new opportunities to market growth. However, the availability of non-invasive alternatives stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Amniocentesis Needle Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 with largest market share owing to robust healthcare infrastructure, sophisticated prenatal care facilities, and a heightened awareness regarding the significance of prenatal testing among expectant parents. The prominent position of North America in the field can be attributed significantly to the widespread availability of cutting-edge diagnostic technologies and innovative genetic testing methods within healthcare facilities. Asia Pacific is expected to grow at a fastest rate during the forecast period. The momentum in this advancement is propelled by a rising awareness of the significance of prenatal care and genetic screening. In countries such as China and India, which boast substantial populations, there is a noticeable surge in the demand for advanced prenatal diagnostics. The increased awareness has resulted in a growing number of pregnant women in Asian countries seeking comprehensive prenatal care. Additionally, continual technological progress in the region, coupled with the emergence of telemedicine and digital healthcare solutions, is broadening the accessibility of prenatal testing services.

Major market player included in this report are:
The Ccoper Companis Inc.
Becton, Dickinson and Company
Cook Medical Incorporated
RI.MOS. Srl
Smiths Medical
Laboratoire Ccd
Integra Lifesciences
Medtronic Plc
Medline Industries Inc.
Biopsybell Srl

Recent Developments in the Market:
 In April 2023, Rocket Pharmaceuticals, a prominent biotechnology company, revealed its plans to bolster its leadership team in response to the expansion of its robust pipeline of AAV and LV gene therapy assets, solidifying its position as an industry leader.
 In February 2022, CooperSurgical successfully completed the acquisition of Cook Medical's reproductive health portfolio for a significant sum of USD 875 million. This portfolio encompasses a diverse range of medical equipment tailored for fertility, obstetrics, gynecology, and in vitro fertilization (IVF).

Global Amniocentesis Needle Market Report Scope:
 Historical Data – 2020 - 2021
 Base Year for Estimation – 2022
 Forecast period - 2023-2030
 Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
 Segments Covered - Type, Procedure, End-use Region
 Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Type:
100 to 150 mm
Smaller Than 100 mm
Larger Than 150 mm

By Procedure:
Amniocentesis Procedures
Amnioreduction Procedures
Fetal Blood Transfusion
Amnioinfusion Procedure
Cordocentesis Procedure

By End-use:
Hospitals
Diagnostics centers
Clinics
Others

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.